These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1935095)

  • 21. Small protective fragments of the Yersinia pestis V antigen.
    Vernazza C; Lingard B; Flick-Smith HC; Baillie LW; Hill J; Atkins HS
    Vaccine; 2009 May; 27(21):2775-80. PubMed ID: 19366573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen.
    Garmory HS; Freeman D; Brown KA; Titball RW
    Vaccine; 2004 Feb; 22(8):947-57. PubMed ID: 15161071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.
    Glynn A; Roy CJ; Powell BS; Adamovicz JJ; Freytag LC; Clements JD
    Infect Immun; 2005 Aug; 73(8):5256-61. PubMed ID: 16041052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of monokines induced by Yersinia pestis EV on the functional activity of neutrophils during development of antiplague immunity].
    Ivanova IA; Vasil'eva GI; Kiseleva AK
    Tsitologiia; 2002; 44(8):799-802. PubMed ID: 12506672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of a vaccinal strain of the plague microbe on C3-receptor expression on the surfaces of peritoneal and alveolar macrophages].
    Vasil'eva GI; Tkachenko LN; Doroshenko EP; Gamleshko KhP; Balatskaia TA
    Mikrobiol Z; 1994; 56(4):25-9. PubMed ID: 9181978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Editorial: Yersinia pestis survives in neutrophils and sends a PS to macrophages: bon appetit!
    Fukuto HS; Bliska JB
    J Leukoc Biol; 2014 Mar; 95(3):383-5. PubMed ID: 24586037
    [No Abstract]   [Full Text] [Related]  

  • 27. Antiplague antibodies against Yersinia pestis fraction-I antigen in serum from rodents either experimentally infected or captured in harbor areas of Japan, 1971--1977.
    Suzuki S; Hotta S
    Microbiol Immunol; 1979; 23(12):1157-68. PubMed ID: 537520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on immunization against plague. V. Multiplication and persistence of virulent and avirulent Pasteurella pestis in mice and guinea pigs.
    WALKER DL; FOSTER LE; CHEN TH; LARSON A; MEYER KF
    J Immunol; 1953 Mar; 70(3):245-52. PubMed ID: 13035114
    [No Abstract]   [Full Text] [Related]  

  • 29. [Adenylate cyclase. A possible factor in the pathogenicity of Yersinia pestis].
    Michankin BN; Chevchenko LA; Asseeva LE
    Bull Soc Pathol Exot; 1992; 85(1):17-21. PubMed ID: 1596952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of the vaccinal strain of Yersinia pestis on the expression of Fc-gamma receptors on macrophage surfaces].
    Vasil'eva GI; Doroshenko EP
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (2):85-6. PubMed ID: 10356746
    [No Abstract]   [Full Text] [Related]  

  • 31. [The phagocytic activity of peritoneal macrophages in relation to Yersinia pestis with defective and complete Fra genes].
    Grebtsova NN; Cherniavskaia AS; Lebedeva SA; Ivanova VS
    Zh Mikrobiol Epidemiol Immunobiol; 1990 May; (5):7-11. PubMed ID: 2386004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of the method of macrophage migration inhibition for titration of toxic activity in microbial fractions].
    Konstantinova NS; Isunov IV; Dzhaparidze MN; Zemtsova IN; Val'vadiants SM
    Lab Delo; 1977; (12):736-9. PubMed ID: 75324
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of an iron drug on host response to experimental plague infection.
    Wake A; Morita H; Yamamoto M
    Jpn J Med Sci Biol; 1972 Apr; 25(2):75-84. PubMed ID: 4540088
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prospects for the use of monoclonal antibodies in Yersinia pestis].
    Temiralieva GA; Arakelian IS; Lukhnova LIu; Apsatarova RA; Kravchenko NP
    Antibiot Khimioter; 1988 Sep; 33(9):687-90. PubMed ID: 3218993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The heterogeneity of the alveolar macrophages of guinea pigs immunized subcutaneously with a vaccinal strain of Yersinia pestis].
    Vasil'eva GI; Gamleshko KhP; Tkachenko LN; Kiseleva AK; Doroshenko AP
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Oct; (10):34-6. PubMed ID: 1801486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of guinea pig plasma factors on phagocytosis of Pasteurella pestis. II. Plasma from plague-infected guinea pigs.
    STANZIALE WG; WHITE JD
    J Bacteriol; 1962 Jan; 83(1):182-6. PubMed ID: 13916284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Survival of EB microbes in live plague vaccine and its immunogeneity in the process of prolonged storage].
    Chicherin IuV; Lebedinskiĭ VA; Evstigneev VI
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Aug; (8):139-40. PubMed ID: 919933
    [No Abstract]   [Full Text] [Related]  

  • 38. A filtered non-toxic plague vaccine which protects guinea-pigs and mice.
    Smith H; Packman LP
    Br J Exp Pathol; 1966 Feb; 47(1):25-34. PubMed ID: 5908699
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of an iron drug on the growth of plague microorganisms in vitro and in guinea pig skin.
    Tsukano H; Yamamoto M; Wake A
    Jpn J Med Sci Biol; 1972 Apr; 25(2):85-93. PubMed ID: 4540089
    [No Abstract]   [Full Text] [Related]  

  • 40. Interaction of Yersinia pestis with mouse peritoneal macrophages in vitro.
    Nakajima R; Namba K; Ishida Y; Une T; Osada Y
    Contrib Microbiol Immunol; 1991; 12():219-24. PubMed ID: 1657519
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.